Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DaRe2THINK
NCT04700826Phase 4Recruiting
- Sponsor
- University of Birmingham
- Start
- Jun 2021
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of apixaban, dabigatran etexilate oral solution, edoxaban, rivaroxaban in Atrial fibrillation (AFib), sponsored by University of Birmingham. Started Jun 2021; status: recruiting.
02
Drugs
apixabandabigatran etexilate oral solutionedoxabanrivaroxaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT04700826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04700826.